“Combined administration of DCA and ATRA significantly reduced the labeling index of colon mucosa, which was increased by DCA, but did not affect the incidence of K‐ras point mutation in colon tumors.”
“Concomitant use of DCA and ATRA at either dose significantly attenuated the enhancement by DCA of colon tumorigenesis.”
“These findings suggest that DCA enhances development of colon tumors and that this enhancement is attenuated by ATRA.”